The market of tissue microarray treatment is growing extensively. It is a practical and effective tool for high-throughput molecular analysis of tissues that is helping to identify new diagnostic and prognostic markers and targets in human cancers, and has a range of potential applications in basic research, prognostic oncology and drug discovery. The growing need of targeted treatments for various chronic diseases like cancer, genetic diseases, among others has boosted the growth of the market.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/1213
According to a recent study report published by the Market Research Future analysts, the global tissue microarray market is growing at a double digit growth rate; mainly due to the increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology are some of the major factors that fosters the growth of global tissue microarray market. Moreover, wide application of tissue microarray in pathology is another factor which is impelling the growth of tissue microarray market.
On the other hand tissue microarray may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumour which may hamper the market growth.
Global Tissue Microarray Market - Competitive Analysis
Abcam plc (U.K), Externautics (Italy), Asterand Bioscience (U.S), Auria Biopankki (Finland), US Biomax Inc. (U.S), Protein Biotechnologies Inc. (U.S), OriGene Technologies Inc (U.S), Novus Biologicals, LLC (U.S) and OriGene Technologies Inc.(U.S) are some of the prominent players at the forefront of competition in the global tissue microarray market and are profiled in MRFR Analysis.
The market of tissue microarray consist of number of players that are involved in the development of the products as well as tests. The companies have involved actively in the development of the advanced products and also some have adopted the strategies of the mergers, acquisitions, and collaborations with other players in order to enhance their business.
Global Tissue Microarray Market - Regional Analysis
The market is flourishing across the globe due to increasing prevalence of cancer and increasing application of tissue microarray in drug discovery. The American market for tissue microarray holds the largest share and it comprises of two regions namely North America and South America. According Centers for Disease Control and Prevention, each year more than 1.5 million cases of cancer are diagnosed, including about 15,000 cases among children younger than 20 years, and more than 590,000 deaths from cancer. Europe holds the second position in the market. Increasing emphasis on rapid diagnosis and treatment of cancer and infectious diseases, change in lifestyle, high prevalence of cancer among geriatric population drives this market in Europe. One of the major application of tissue microarray being the cancer diagnostics, the prevalence of the cancer in particular region has a lot to with the growth of this market. Asia Pacific region is one of the fastest growing market owing to the rapidly growing economies and increasing expenditure on the research & development.
According to WHO, cancer is a leading cause of death and accounted for 7.6 million deaths in 2008. Deaths from cancer worldwide are projected to continue to rise to over 13.1 million in 2030. Presently in India, it is a major cause of morbidity and mortality. Cancers are caused by risk factors such as tobacco use, alcohol use, unhealthy diet and physical inactivity, amongst others. These statistics are evident to highlight the problem of cancer in Asia Pacific, thus acting as an emerging market. The Middle East and Africa show steady growth in the tissue Microarray market. Lack of advanced medical facilities and less improvement in healthcare have somehow thwarted the growth of the market in this region.
Access Report Details @
https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
It is a practical and effective tool for high-throughput molecular analysis of tissues that is helping to identify new diagnostic and prognostic markers and targets in human cancers, and has a range of potential applications in basic research, prognostic oncology and drug discovery.
The growing need of targeted treatments for various chronic diseases like cancer, genetic diseases, among others has boosted the growth of the market.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/1213According to a recent study report published by the Market Research Future analysts, the global tissue microarray market is growing at a double digit growth rate; mainly due to the increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology are some of the major factors that fosters the growth of global tissue microarray market.
Moreover, wide application of tissue microarray in pathology is another factor which is impelling the growth of tissue microarray market.On the other hand tissue microarray may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumour which may hamper the market growth.
Global Tissue Microarray Market - Competitive AnalysisAbcam plc (U.K), Externautics (Italy), Asterand Bioscience (U.S), Auria Biopankki (Finland), US Biomax Inc. (U.S), Protein Biotechnologies Inc. (U.S), OriGene Technologies Inc (U.S), Novus Biologicals, LLC (U.S) and OriGene Technologies Inc.(U.S) are some of the prominent players at the forefront of competition in the global tissue microarray market and are profiled in MRFR Analysis.
The American market for tissue microarray holds the largest share and it comprises of two regions namely North America and South America.
According Centers for Disease Control and Prevention, each year more than 1.5 million cases of cancer are diagnosed, including about 15,000 cases among children younger than 20 years, and more than 590,000 deaths from cancer.
